Volume | 75,861 |
|
|||||
News | - | ||||||
Day High | 1.33 | Low High |
|||||
Day Low | 1.22 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Passage Bio Inc | PASG | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.22 | 1.22 | 1.33 | 1.32 | 1.22 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
428 | 75,861 | $ 1.27 | $ 96,243 | - | 0.5751 - 1.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:54:00 | 50 | $ 1.32 | USD |
Passage Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
72.28M | 55.60M | - | 0 | -102.06M | -1.84 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Passage Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PASG Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.20 | 1.33 | 1.1006 | 1.17 | 93,711 | 0.07 | 5.83% |
1 Month | 1.36 | 1.45 | 1.1006 | 1.30 | 132,110 | -0.09 | -6.62% |
3 Months | 0.97 | 1.79 | 0.9381 | 1.39 | 364,492 | 0.30 | 30.93% |
6 Months | 0.67 | 1.79 | 0.5751 | 1.01 | 500,814 | 0.60 | 89.55% |
1 Year | 0.99 | 1.79 | 0.5751 | 0.9652053 | 353,387 | 0.28 | 28.28% |
3 Years | 16.94 | 19.84 | 0.5751 | 4.05 | 331,625 | -15.67 | -92.50% |
5 Years | 22.27 | 38.23 | 0.5751 | 8.09 | 316,208 | -21.00 | -94.30% |
Passage Bio Description
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. |